A citation-based method for searching scientific literature

V Máximo, T Botelho, J Capela, P Soares, J Lima, A Taveira, T Amaro, A P Barbosa, A Preto, H R Harach, D Williams, M Sobrinho-Simões. Br J Cancer 2005
Times Cited: 149







List of co-cited articles
1178 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.
Giuseppe Gasparre, Anna Maria Porcelli, Elena Bonora, Lucia Fiammetta Pennisi, Matteo Toller, Luisa Iommarini, Anna Ghelli, Massimo Moretti, Christine M Betts, Giuseppe Nicola Martinelli,[...]. Proc Natl Acad Sci U S A 2007
190
29


Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
Elena Bonora, Anna Maria Porcelli, Giuseppe Gasparre, Annalisa Biondi, Anna Ghelli, Valerio Carelli, Alessandra Baracca, Giovanni Tallini, Andrea Martinuzzi, Giorgio Lenaz,[...]. Cancer Res 2006
169
26

GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction.
Chengchen Lufei, Jing Ma, Guochang Huang, Tong Zhang, Veronica Novotny-Diermayr, Chin Thing Ong, Xinmin Cao. EMBO J 2003
189
25

GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I.
Guochang Huang, Hao Lu, Aijun Hao, Dominic C H Ng, Sathivel Ponniah, Ke Guo, Chengchen Lufei, Qi Zeng, Xinmin Cao. Mol Cell Biol 2004
158
23

A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas.
I Alchanati, S C Nallar, P Sun, L Gao, J Hu, A Stein, E Yakirevich, D Konforty, I Alroy, X Zhao,[...]. Oncogene 2006
79
27

The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.
Jun Zhang, Jinbo Yang, Sanjit K Roy, Silvia Tininini, Jiadi Hu, Jacqueline F Bromberg, Valeria Poli, George R Stark, Dhananjaya V Kalvakolanu. Proc Natl Acad Sci U S A 2003
144
20

Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ian Ganly, Julio Ricarte Filho, Stephanie Eng, Ronald Ghossein, Luc G T Morris, Yupu Liang, Nicholas Socci, Kasthuri Kannan, Qianxing Mo, James A Fagin,[...]. J Clin Endocrinol Metab 2013
109
20



Oncocytic tumours.
G Tallini. Virchows Arch 1998
136
17

The biology and the genetics of Hurthle cell tumors of the thyroid.
Valdemar Máximo, Jorge Lima, Hugo Prazeres, Paula Soares, Manuel Sobrinho-Simões. Endocr Relat Cancer 2012
48
35



RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
Marina N Nikiforova, Roy A Lynch, Paul W Biddinger, Erik K Alexander, Gerald W Dorn, Giovanni Tallini, Todd G Kroll, Yuri E Nikiforov. J Clin Endocrinol Metab 2003
480
16

A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2.
F Canzian, P Amati, H R Harach, J L Kraimps, F Lesueur, J Barbier, P Levillain, G Romeo, D Bonneau. Am J Hum Genet 1998
184
16

GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH:ubiquinone oxidoreductase (complex I).
I M Fearnley, J Carroll, R J Shannon, M J Runswick, J E Walker, J Hirst. J Biol Chem 2001
197
16


Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.
Ying Zhou, Min Li, Ying Wei, Dingqing Feng, Cheng Peng, Haiyan Weng, Yang Ma, Liang Bao, Shreeram Nallar, Sudhakar Kalakonda,[...]. J Interferon Cytokine Res 2009
37
40

Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.
Ling Zhang, Lifang Gao, Yang Li, Guimiao Lin, Yueting Shao, Kun Ji, Hao Yu, Jiadi Hu, Dhananjaya V Kalvakolanu, Dennis J Kopecko,[...]. Clin Cancer Res 2008
76
19


PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
T G Kroll, P Sarraf, L Pecciarini, C J Chen, E Mueller, B M Spiegelman, J A Fletcher. Science 2000
627
13

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Ginesa Garcia-Rostan, Hongyu Zhao, Robert L Camp, Marina Pollan, Agustin Herrero, Javier Pardo, Ran Wu, Maria Luisa Carcangiu, Jose Costa, Giovanni Tallini. J Clin Oncol 2003
262
12

Chromosomal aberrations by comparative genomic hybridization in hürthle cell thyroid carcinomas are associated with tumor recurrence.
Nobuyuki Wada, Quan-Yang Duh, Daishu Miura, Laurent Brunaud, Mariwil G Wong, Orlo H Clark. J Clin Endocrinol Metab 2002
45
26

Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3.
Sudhakar Kalakonda, Shreeram C Nallar, Daniel J Lindner, Jiadi Hu, Sekhar P Reddy, Dhananjaya V Kalvakolanu. Cancer Res 2007
37
32

Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.
Willem E Corver, Dina Ruano, Karin Weijers, Wietske C E den Hartog, Merlijn P van Nieuwenhuizen, Noel de Miranda, Ronald van Eijk, Anneke Middeldorp, Ekaterina S Jordanova, Jan Oosting,[...]. PLoS One 2012
44
27

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
12


Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.
Zhaowen Zhu, Manoj Gandhi, Marina N Nikiforova, Andrew H Fischer, Yuri E Nikiforov. Am J Clin Pathol 2003
285
11

Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
Giuseppe Gasparre, Eric Hervouet, Elodie de Laplanche, Jocelyne Demont, Lucia Fiammetta Pennisi, Marc Colombel, Florence Mège-Lechevallier, Jean-Yves Scoazec, Elena Bonora, Roel Smeets,[...]. Hum Mol Genet 2008
106
11

Function of mitochondrial Stat3 in cellular respiration.
Joanna Wegrzyn, Ramesh Potla, Yong-Joon Chwae, Naresh B V Sepuri, Qifang Zhang, Thomas Koeck, Marta Derecka, Karol Szczepanek, Magdalena Szelag, Agnieszka Gornicka,[...]. Science 2009
680
11

[Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].
Long-Bo Gong, Xue-Lai Luo, Shuang-You Liu, De-Ding Tao, Jian-Ping Gong, Jun-Bo Hu. Ai Zheng 2007
19
57

Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth.
Takashi Okamoto, Takashi Inozume, Hiroshi Mitsui, Mirei Kanzaki, Kazutoshi Harada, Naotaka Shibagaki, Shinji Shimada. Mol Cancer Ther 2010
31
35


Clinical and molecular features of Hürthle cell carcinoma of the thyroid.
Ana-Maria Chindris, John D Casler, Victor J Bernet, Michael Rivera, Colleen Thomas, Jennifer M Kachergus, Brian M Necela, Ian D Hay, Sydney A Westphal, Clive S Grant,[...]. J Clin Endocrinol Metab 2015
59
18

Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.
Ian Ganly, Vladimir Makarov, Shyamprasad Deraje, YiYu Dong, Ed Reznik, Venkatraman Seshan, Gouri Nanjangud, Stephanie Eng, Promita Bose, Fengshen Kuo,[...]. Cancer Cell 2018
103
11

Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Luis Lopez-Penabad, Alice C Chiu, Ana O Hoff, Pamela Schultz, Sonia Gaztambide, Nelson G Ordoñez, Steven I Sherman. Cancer 2003
113
10


Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
Vítor Trovisco, Paula Soares, Ana Preto, Inês Vieira de Castro, Jorge Lima, Patrícia Castro, Valdemar Máximo, Tiago Botelho, Severina Moreira, Ana Margarida Meireles,[...]. Virchows Arch 2005
211
10

Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors.
F Savagner, B Franc, S Guyetant, P Rodien, P Reynier, Y Malthiery. J Clin Endocrinol Metab 2001
78
12

Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
Johannes A Mayr, David Meierhofer, Franz Zimmermann, Rene Feichtinger, Christian Kögler, Manfred Ratschek, Nikolaus Schmeller, Wolfgang Sperl, Barbara Kofler. Clin Cancer Res 2008
117
10

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Marina N Nikiforova, Edna T Kimura, Manoj Gandhi, Paul W Biddinger, Jeffrey A Knauf, Fulvio Basolo, Zhaowen Zhu, Riccardo Giannini, Giuliana Salvatore, Alfredo Fusco,[...]. J Clin Endocrinol Metab 2003
760
10

Thyroid pathologic findings in patients with Cowden disease.
H R Harach, I Soubeyran, A Brown, D Bonneau, M Longy. Ann Diagn Pathol 1999
75
13


Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
275
10

Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma.
Raj K Gopal, Kirsten Kübler, Sarah E Calvo, Paz Polak, Dimitri Livitz, Daniel Rosebrock, Peter M Sadow, Braidie Campbell, Samuel E Donovan, Salma Amin,[...]. Cancer Cell 2018
97
10


On the origin of cancer cells.
O WARBURG. Science 1956
9

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
Peng Hou, Dingxie Liu, Yuan Shan, Shuiying Hu, Kimberley Studeman, Stephen Condouris, Yangang Wang, Ariel Trink, Adel K El-Naggar, Giovanni Tallini,[...]. Clin Cancer Res 2007
284
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.